Pricing Log in Create free account
Friday 6 November 2026 Export SCL’s income statement to Excel — free account

Stepan Company

SCL Basic Materials Specialty Chemicals

Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024.

Revenue
+17.3%
EPS
+65.5%
Free cash flow
−4.42%
Total debt
−47.9%

Quarter to September 2026, against a year earlier

67.71 2.94 −4.16%
Market cap
$1.5B
P/E
361×
Fwd P/E
−435×
Dividend yield
2.33%
F-score
5/9
Altman Z
2.54
Beneish M
−2.66
Dividend safety
65/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 5.66%

Capital & Financial Ratios $m

Size
Market Cap 1,540.00
Revenue ttm 2,534.66
Net income ttm (2.65)
Free cash flow ttm 63.17
Net debt Q 341.69
Valuation
P/E 360.74 (above 35: high)
Forward P/E (435.00) (negative: loss-making)
Price / sales 0.61
Forward P/S Powerpack
Price / FCF 23.35
Price / book 1.28
Financial health
Current ratio Q 1.32
Debt / equity Q 0.28 (at or below 0.5: strong)
Interest coverage Q 4.09
Growth
Revenue growth Q +17.26% (above 0%: growing)
Operating income growth Q +19.11% (above 0%: growing)
EPS, this year +52.75% (at or above 15%: strong)
EPS, next year A +33.81% (at or above 15%: strong)
Revenue, next year A +8.57%
EPS, past 5 yrs −17.76% (below 0%: weak)
EPS, next 5 yrs A +28.24% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.9×, against a ten-year median of 1.0×; over the ten years it ranged from 0.7× in 2016 to 1.6× in 2021.
P/E against its own 10 years 99.77%
10-year low 10-year high
P/S against its own 10 years 15.80%
10-year low 10-year high
P/B against its own 10 years 17.16%
10-year low 10-year high
EV/Sales against its own 10 years 20.24%
10-year low 10-year high
EV/FCF against its own 10 years 77.36%
10-year low 10-year high

Dividends raised 2 years running

Yield
2.33%
Annual rate
1.58
Payout ratio
853.1%
Growth, 2017–25
+7.96%/yr
  1. 0.84 ’17
  2. 0.93 ’18 +10
  3. 1.03 ’19 +11
  4. 1.13 ’20 +10
  5. 1.25 ’21 +11
  6. 1.74 ’22 +39
  7. 1.47 ’23 −15
  8. 1.51 ’24 +3
  9. 1.55 ’25 +3
  10. 1.60 ’26e +3
paid forecast change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 130 100 133 —
Receivables 422 388 388 —
Inventory 266 289 299 —
Other 34 34 39 —
852 810 859 983
2023 2024 2025 Q'26
Payables 233 259 262 —
ST’ Debt 253 293 286 —
Other — — — —
608 669 666 743

Compound Annual Growth %

10y 5y 3y
Sales 2.76% 4.52% (5.61%)
Cash Flow (2.15%) (8.86%) (2.75%)
Earnings (4.71%) (18.04%) (31.70%)
Book Value 8.34% 4.71% 2.18%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.73 Actual 0.94

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.35 −0.02 Miss by 0.37
Q1 FY26 0.21 0.45 Beat by 0.24
Q2 FY26 0.61 1.18 Beat by 0.57
Q3 FY26 0.73 0.94 Beat by 0.21
Q4 FY26 0.34 — Reports 22 February 2027

EPS $

Mar Jun Sep Dec Year
’26 (1.81) 1.00 0.78 — —
’25 0.86 0.50 0.47 0.22 2.05
’24 0.61 0.42 1.03 0.15 2.20
’23 0.70 0.55 0.55 (0.05) 1.75
’22 1.93 2.26 1.71 0.47 6.38
’21 1.74 1.85 1.59 0.73 5.92
’20 1.18 1.54 1.43 1.30 5.45
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 605 684 692 — —
’25 593 595 590 554 2,332
’24 551 556 547 526 2,180
’23 651 580 562 532 2,326
’22 675 752 719 627 2,773
’21 538 596 603 610 2,346
’20 450 461 464 495 1,870
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 17 8 — — —
’25 7 11 70 60 148
’24 42 30 23 68 162
’23 (72) 108 70 69 175
’22 (21) 59 37 86 161
’21 (12) 36 (3) 51 72
’20 (6) 65 83 94 235
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (14) (15) — — —
’25 (26) (14) 40 52 52
’24 11 0 (4) 32 39
’23 (164) 40 16 22 (85)
’22 (81) (10) (39) (10) (141)
’21 (53) (1) (44) (24) (122)
’20 (42) 44 53 53 107
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 1,766 1,925 1,994 1,859 1,870 2,346 2,773 2,326 2,180 2,332 2,535 +3.1% 2,532 2,682 2,770 +5.9%
Gross margin, % 19.21 17.98 17.02 18.28 20.52 16.87 15.40 11.94 12.49 11.57 11.99 (7.6) pt
EBT 114 147 138 126 171 173 189 48 60 60 3 (6.9%)
EBT margin, % 6.44 7.63 6.91 6.77 9.15 7.35 6.80 2.08 2.77 2.57 0.11 (3.9) pt
Net income 86 101 111 103 128 138 147 40 50 47 (3) (6.5%)
Per share, $
Per share, $ Revenue 77.49 83.89 86.61 80.63 81.47 102.35 121.74 102.11 95.49 101.96 110.65 +3.1%
Earnings 3.78 3.99 4.90 4.47 5.52 6.01 6.46 1.77 2.21 2.05 0.19 (6.6%)
Cash flow 9.31 8.67 7.43 9.47 10.25 3.15 7.06 7.68 7.10 6.47 0.00 (4.0%)
Capex (4.52) (3.43) (3.76) (4.58) (5.57) (8.46) (13.24) (11.43) (5.38) (4.19) 0.00 (0.8%)
Free cash flow 4.79 5.24 3.67 4.90 4.68 (5.31) (6.18) (3.75) 1.72 2.27 0.00 (7.9%)
Book value 27.90 32.29 35.10 38.71 43.07 46.86 51.19 53.41 51.24 54.39 53.21 +7.7%
Shares, m 23 23 23 23 23 23 23 23 23 23 23 0.0%
Valuation, ×
Valuation, × P/E 21.75 18.22 15.13 22.92 21.58 20.68 16.12 52.79 29.28 23.10 360.74 24.2
P/S 1.04 0.95 0.85 1.27 1.46 1.21 0.86 0.92 0.68 0.46 0.61 1.0
P/B 2.89 2.47 2.11 2.65 2.77 2.65 2.03 1.75 1.26 0.87 1.28 2.1
EV/Sales 1.09 0.95 0.84 1.22 1.38 1.30 1.00 1.14 0.92 0.68 0.86 1.1
EV/FCF 17.19 14.76 19.14 19.54 23.38 (25.78) (20.26) (32.27) 47.09 28.56 32.85 9.1
Cash, $m
Cash, $m Operating cash flow 212 199 171 218 235 72 161 175 162 148 155 (3.9%)
Capex (103) (79) (87) (106) (128) (194) (302) (260) (123) (96) (92) (0.8%)
Free cash flow 109 120 84 113 107 (122) (141) (85) 39 52 63 (7.9%)
Balance, $m
Balance, $m Working capital 388 468 495 480 489 413 374 244 141 192 240 (7.5%)
Net debt 91 (8) (24) (93) (151) 204 413 524 526 494 342 +20.6%
Shareholders’ equity 636 741 808 892 988 1,074 1,166 1,216 1,170 1,244 1,219 +7.7%
Returns, %
Returns, % ROA 6.65 7.14 7.44 6.67 7.61 7.22 6.54 1.68 2.16 2.01 0.18 (4.6) pt
ROIC 10.99 13.21 11.90 9.95 12.81 8.35 8.20 2.10 2.60 2.82 0.96 (8.2) pt
ROE 14.43 14.64 14.35 12.13 13.48 13.36 13.14 3.37 4.22 3.89 0.00 (10.5) pt
People
People Employees 2,145 2,096 2,250 2,284 2,293 2,439 2,453 2,389 2,396 2,328 — +0.9%
Revenue/emp, $m 0.82 0.92 0.89 0.81 0.82 0.96 1.13 0.97 0.91 1.00 — +2.2%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Stepan Company vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
KWR Quaker Houghton $2.6B 27.2× 21.6× +10.27% (above 0%: growing) −0.42% (below 0%: shrinking) −92.40% (below 0%: shrinking) 35.54% 8.97% Compare
NGVT Ingevity Corporation $2.2B 42.0× 18.4× −5.25% (below 0%: shrinking) n/m −136.08% (below 0%: shrinking) 44.25% 19.13% Compare
IOSP Innospec Inc. $2.0B 13.9× 19.5× +7.17% (above 0%: growing) +146.71% (above 0%: growing) −88.68% (below 0%: shrinking) 27.26% 8.80% Compare
MTX Minerals Technologies Inc. $1.9B — (loss-making) — (loss-making) +4.23% (above 0%: growing) +2.80% (above 0%: growing) +19.04% (above 0%: growing) 23.28% 11.68% Compare
CC The Chemours Company $1.9B — (loss-making) — (loss-making) +3.01% (above 0%: growing) +223.80% (above 0%: growing) −12.50% (below 0%: shrinking) 15.00% 14.87% Compare
STDN Standard Nuclear Inc $1.8B — — — n/m — 67.21% (90.70%) Compare
SCL Stepan Company $1.5B 361× — (loss-making) +17.26% (above 0%: growing) +65.47% (above 0%: growing) −4.42% (below 0%: shrinking) 12.65% 3.75%
ECVT Ecovyst Inc. $1.1B — (loss-making) 14.5× +41.97% (above 0%: growing) +40.00% (above 0%: growing) −66.55% (below 0%: shrinking) 19.94% 7.75% Compare
ODC Oil-Dri Corporation Of America $920.5M 16.5× 37.5× +3.26% (above 0%: growing) +11.46% (above 0%: growing) −20.76% (below 0%: shrinking) 27.83% 14.11% Compare
Median of peers $1.9B 21.8× 19.5× +4.23% +25.73% −66.55% 27.55% 10.33%

All 61 Specialty Chemicals stocks →

Stepan Company (SCL) Latest News

28 Oct

Impact 4 · · The Motley Fool transcript
Impact 4 · · Moby transcript
Impact 4 · · MarketBeat
Impact 4 · · PR Newswire
Impact 3 · · Associated Press
Impact 3 · · 24/7 Wall St.
Impact 3 · · Zacks
Impact 3 · · PR Newswire

30 Sep

Impact 3 · · Zacks

28 Aug

Impact 4 · · MarketBeat

7 Aug

Impact 3 · · The Motley Fool transcript

31 Jul

Impact 3 ·

30 Jul

Impact 3 · · MarketBeat

29 Jul

Impact 3 · · Moby transcript
Impact 3 ·
Impact 3 ·

8 Jul

Impact 3 · · Trefis

29 Apr

Impact 3 · · GuruFocus.com

28 Apr

Impact 4 · · The Motley Fool transcript
Impact 3 · · MarketBeat
Impact 3 · · Moby
Impact 3 · · Zacks
Impact 3 · · PR Newswire

21 Apr

Impact 3 ·

25 Feb

Impact 4 · · Insider Monkey

24 Feb

Impact 4 · · Simply Wall St.

23 Feb

Impact 4 · · GuruFocus.com
Impact 4 · · MarketBeat
Impact 4 · · Moby
Impact 3 · · Zacks
stockrow.com/SCL · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com